Oxygenta Pharmaceutical Ltd

Fri 4/09/2026,15:27:0 | BSE : OXYGENTAPH

₹54.05-1.88 (-3.36%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 55.90

Previous Close

₹ 55.93

Volume

37087

Mkt Cap ( ₹ Cr)

₹ 199.90

High

₹ 58.71

Low

₹ 54.00

52 Week High

₹ 75.00

52 Week Low

₹ 43.00

Book Value Per Share

₹ -12.11

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Oxygenta Pharmaceutical Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Oxygenta Pharmaceutical Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Oxygenta Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    21 Aug 2026, 4:52PM Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.

  • Oxygenta Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM

    21 Aug 2026, 4:48PM Outcome of 33rd Annual General Meeting held on 21.08.2026.

  • Oxygenta Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    21 Aug 2026, 4:52PM Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.

  • Oxygenta Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    21 Aug 2026, 4:52PM Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.

  • Oxygenta Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    21 Aug 2026, 4:52PM Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.

  • Oxygenta Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    21 Aug 2026, 4:52PM Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.

  • Oxygenta Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    21 Aug 2026, 4:52PM Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.

  • Oxygenta Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    21 Aug 2026, 4:52PM Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.

  • Oxygenta Pharma. - Newspaper Advertisement

    31 Jul 2026, 12:09PM Newspaper Advertisement for Notice of AGM scheduled to be held on 21st August, 2026.

  • Oxygenta Pharma. - Intimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of Oxygenta Pharmaceutical

    30 Jul 2026, 5:13PM Intimation of Book Closure and Cut-off Date for the AGM

  • Oxygenta Pharma. - Reg. 34 (1) Annual Report.

    30 Jul 2026, 5:07PM Submission of 33rd Annual Report for the Financial Year 2025-26 under Regulation 34 of SEBI (LODR), Regulations, 2015

  • Oxygenta Pharma. - Submission Of Notice Of 33Rd Annual General Meeting For The Finanical Year 2025-26.

    30 Jul 2026, 5:00PM Notice of 33rd Annual General Meeting for the Financial Year 2025-26.

  • Oxygenta Pharma. - Announcement under Regulation 30 (LODR)-Change in Management

    27 Jul 2026, 6:15PM Appointment of Cost Auditor for the Financial Year 2026-27.

  • Oxygenta Pharma. - Un-Audited Results For The Quarter Ended 30.06.2026.

    27 Jul 2026, 6:13PM Un-audited Financial Results for the Quarter ended 30.06.2026.

  • Oxygenta Pharma. - Board Meeting Outcome for Outcome For The Board Meeting Held On 27.07.2026

    27 Jul 2026, 6:05PM Un-audited Financial results for the Quarter ended 30.06.2026.

  • Oxygenta Pharma. - Update on board meeting

    24 Jul 2026, 4:06PM The Board Meeting to be held on 25/07/2026 has been revised to 27/07/2026 Postponement of the Board Meeting to be held on Saturday, 25th July, 2026 an

  • Oxygenta Pharma. - Board Meeting Intimation for The Meeting To Be Held On Saturday, 25Th Day Of July, 2026

    22 Jul 2026, 3:30PM Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consi

  • Oxygenta Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    18 Jul 2026, 7:00PM As of June 2026, 56.53% is owned by Indian Promoters and 43.46% by Public. <p align=justify> Top two Promoters holding highest number of shares of Oxy

  • Oxygenta Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jul 2026, 2:51PM Compliance as per Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Oxygenta Pharmaceutical Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 66.88 37.2076 37.1113 21.7934 17.4997
Liabilities 66.88 37.2076 37.1113 21.7934 17.4997
Equity 36.9835 36.9835 33.4835 14.2013 14.2013
Gross Profit -15.3527 -9.9947 -9.6965 -7.1168 1.4759
Net Profit -17.5717 -9.6826 -3.4793 -11.5709 -0.6104
Cash From Operating Activities -27.753 2.6028 -13.0496 -1.6336 -1.6799
NPM(%) -15.55 -8.85 -8.77 -37.34 -1
Revenue 112.9819 109.2986 39.6421 30.9874 60.5248
Expenses 128.3346 119.2933 49.3386 38.1042 59.0488
ROE(%) 39.23 21.61 7.76 25.83 1.36

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Oxygenta Pharmaceutical Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 863.00 -0.52 21.76 30.92 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 109.90 -0.68 1563.29 112.67 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.42 0.72 0.00 233.95 -39.50 0.00
Astec Lifesciences Ltd 552.30 -3.93 0.00 120.72 -363.14 0.00

Company Info

OXYGENTA PHARMACEUTICAL LIMITED was incorporated as Private Limited Company in the year 1990 and subsequently converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. 1990 - The company was incorporated and its main line of business was bulk drugs. 1994 - The company had entered into an MOU with ICD group BV of Netherlands. As per the agreement, ICD would purchase 36 tonnes a year of mebadazole and 12 tonnes of atenolol for a period of five years from the company. 1998 - The company was turned sick and was registered with BIFR. 2003 -The board of the company had approved to convert the unsecured loans of Rs 2 crore into 20 lakh equity shares of Rs 10 each. - The board had also proposed to increase the authorized capital to Rs 8 crore from the existing level of Rs 6 crore. 2006 - Mr. Y Ramachandra Reddy (joint managing director), Mr. E Rama Subba Reddy (director) and Mr. G Chandramoulieswar Reddy (director) had resigned from the board of directors of the company. 2007 - Board of directors of the company on 4th April had passed the resolution to extend the financial year of the company to 15 months. 2008 - The Board of the company had appointed Mr. MG Naidu as independent director of the company. 2022 -Company name has changed to Oxygenta Pharmaceutical Ltd. from S S Organics Ltd..

OXYGENTA PHARMACEUTICAL LIMITED was incorporated as Private Limited Company in the year 1990 and subsequently converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. 1990 - The company was incorporated and its main line of business was bulk drugs. 1994 - The company had entered into an MOU with ICD group BV of Netherlands. As per the agreement, ICD would purchase 36 tonnes a year of mebadazole and 12 tonnes of atenolol for a period of five years from the company. 1998 - The company was turned sick and was registered with BIFR. 2003 -The board of the company had approved to convert the unsecured loans of Rs 2 crore into 20 lakh equity shares of Rs 10 each. - The board had also proposed to increase the authorized capital to Rs 8 crore from the existing level of Rs 6 crore. 2006 - Mr. Y Ramachandra Reddy (joint managing director), Mr. E Rama Subba Reddy (director) and Mr. G Chandramoulieswar Reddy (director) had resigned from the board of directors of the company. 2007 - Board of directors of the company on 4th April had passed the resolution to extend the financial year of the company to 15 months. 2008 - The Board of the company had appointed Mr. MG Naidu as independent director of the company. 2022 -Company name has changed to Oxygenta Pharmaceutical Ltd. from S S Organics Ltd..

Parent Organisation

Oxygenta Pharmaceutical Ltd.

Founded

27/11/1990

Managing Director

NSE Symbol

FAQ